标题
Targeted therapies for systemic sclerosis
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 9, Issue 8, Pages 451-464
出版商
Springer Nature
发表日期
2013-04-09
DOI
10.1038/nrrheum.2013.46
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bosentan Treatment for Raynaud's Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and Pulmonary Arterial Hypertension: An Open-Label, Observational, Retrospective Study
- (2017) N. Giordano et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- LB0002 The astis trial: Autologous stem cell transplantation versus IV pulse cyclophosphamide in poor prognosis systemic sclerosis, first results
- (2014) J.M. van Laar et al. ANNALS OF THE RHEUMATIC DISEASES
- Interspecies Comparison of Human and Murine Scleroderma Reveals IL-13 and CCL2 as Disease Subset-Specific Targets
- (2012) Matthew B. Greenblatt et al. AMERICAN JOURNAL OF PATHOLOGY
- Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
- (2012) Angelika Horn et al. ANNALS OF THE RHEUMATIC DISEASES
- The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis
- (2012) Gerhard Krönke et al. ANNALS OF THE RHEUMATIC DISEASES
- Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
- (2012) Estrella Garcia Gonzalez et al. ANNALS OF THE RHEUMATIC DISEASES
- Pomalidomide is effective for prevention and treatment of experimental skin fibrosis
- (2012) Simon Weingärtner et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis
- (2012) Korsa Khan et al. ANNALS OF THE RHEUMATIC DISEASES
- The interferon signature andSTAT1expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment
- (2012) Rachael A. Gordon et al. ARTHRITIS AND RHEUMATISM
- JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis
- (2012) Clara Dees et al. ARTHRITIS AND RHEUMATISM
- Epigenetic patterns in systemic sclerosis and their contribution to attenuated CD70 signaling cascades
- (2012) Christian M. Hedrich et al. CLINICAL IMMUNOLOGY
- Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats
- (2012) M. Samah et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy
- (2012) Gregory J. Keir et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacological blockade of adenosine A2A receptors diminishes scarring
- (2012) Miguel Perez-Aso et al. FASEB JOURNAL
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
- (2012) Fanli Meng et al. GASTROENTEROLOGY
- Unraveling the genetic component of systemic sclerosis
- (2012) José Ezequiel Martín et al. HUMAN GENETICS
- Effect of Resveratrol on Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats
- (2012) Recep Akgedik et al. INFLAMMATION
- Molecular pathogenesis of pulmonary arterial hypertension
- (2012) Marlene Rabinovitch JOURNAL OF CLINICAL INVESTIGATION
- Impaired IL-17 Signaling Pathway Contributes to the Increased Collagen Expression in Scleroderma Fibroblasts
- (2012) T. Nakashima et al. JOURNAL OF IMMUNOLOGY
- TGF- -Mediated Downregulation of MicroRNA-196a Contributes to the Constitutive Upregulated Type I Collagen Expression in Scleroderma Dermal Fibroblasts
- (2012) N. Honda et al. JOURNAL OF IMMUNOLOGY
- Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury
- (2012) Sonja Djudjaj et al. JOURNAL OF PATHOLOGY
- Familial Autoimmunity in Systemic Sclerosis -- Results of a French-based Case-Control Family Study
- (2012) E. KOUMAKIS et al. JOURNAL OF RHEUMATOLOGY
- Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease
- (2012) Ran Reshef et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome
- (2012) Jean Y. Tang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Periostin Facilitates Skin Sclerosis via PI3K/Akt Dependent Mechanism in a Mouse Model of Scleroderma
- (2012) Lingli Yang et al. PLoS One
- Sustained improvement of diffuse systemic sclerosis following human cytomegalovirus infection offers insight into pathogenesis and therapy
- (2012) P. Moinzadeh et al. RHEUMATOLOGY
- Integrins as therapeutic targets
- (2012) Simon L. Goodman et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial
- (2012) Dona L Fleishaker et al. ARTHRITIS RESEARCH & THERAPY
- Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
- (2012) Alfiya Akhmetshina et al. Nature Communications
- Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial
- (2011) R. F. Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis
- (2011) Clara Dees et al. ARTHRITIS AND RHEUMATISM
- Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis
- (2011) Ariane L. Herrick et al. ARTHRITIS AND RHEUMATISM
- Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center
- (2011) Janet Pope et al. ARTHRITIS AND RHEUMATISM
- Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma
- (2011) Flavia V. Castelino et al. ARTHRITIS AND RHEUMATISM
- Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis
- (2011) Jérôme Avouac et al. ARTHRITIS AND RHEUMATISM
- Effects of bosentan on nondigital ulcers in patients with systemic sclerosis
- (2011) T. Taniguchi et al. BRITISH JOURNAL OF DERMATOLOGY
- Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ
- (2011) Huizhi Du et al. BRITISH JOURNAL OF PHARMACOLOGY
- Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1
- (2011) Anthony J. Valente et al. CELLULAR SIGNALLING
- Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis
- (2011) K. P. Tiev et al. EUROPEAN RESPIRATORY JOURNAL
- Selective Endothelin-A Receptor Antagonism Reduces Proteinuria, Blood Pressure, and Arterial Stiffness in Chronic Proteinuric Kidney Disease
- (2011) Neeraj Dhaun et al. HYPERTENSION
- Platelet-derived serotonin links vascular disease and tissue fibrosis
- (2011) Clara Dees et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Blocking IL-17A Promotes the Resolution of Pulmonary Inflammation and Fibrosis Via TGF- 1-Dependent and -Independent Mechanisms
- (2011) S. Mi et al. JOURNAL OF IMMUNOLOGY
- Effect of Bosentan on Systemic Sclerosis-associated Interstitial Lung Disease Ineligible for Cyclophosphamide Therapy: A Prospective Open-label Study
- (2011) YOSHIAKI FURUYA et al. JOURNAL OF RHEUMATOLOGY
- Clinical and Serological Hallmarks of Systemic Sclerosis Overlap Syndromes
- (2011) A. PAKOZDI et al. JOURNAL OF RHEUMATOLOGY
- Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
- (2011) Richard K Burt et al. LANCET
- Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
- (2011) Swati Bhattacharyya et al. Nature Reviews Rheumatology
- HSCT for systemic sclerosis—swallows and summers
- (2011) Alan Tyndall Nature Reviews Rheumatology
- Asthma Phenotypes and Interleukin-13 — Moving Closer to Personalized Medicine
- (2011) Monica Kraft NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Possible strategies for anti-fibrotic drug intervention in scleroderma
- (2011) Andrew Leask Journal of Cell Communication and Signaling
- Resveratrol Inhibits Renal Fibrosis in the Obstructed Kidney
- (2010) Jinhua Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
- (2010) Hossein A. Ghofrani et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
- (2010) E. Balistreri et al. ANNALS OF THE RHEUMATIC DISEASES
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
- (2010) A. J. Tyndall et al. ANNALS OF THE RHEUMATIC DISEASES
- Involvement of functional autoantibodies against vascular receptors in systemic sclerosis
- (2010) G. Riemekasten et al. ANNALS OF THE RHEUMATIC DISEASES
- Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
- (2010) M. Matucci-Cerinic et al. ANNALS OF THE RHEUMATIC DISEASES
- A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis
- (2010) G. Farina et al. ARTHRITIS AND RHEUMATISM
- Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis
- (2010) Sieglinde Marquart et al. ARTHRITIS AND RHEUMATISM
- Animal models of systemic sclerosis: Prospects and limitations
- (2010) Christian Beyer et al. ARTHRITIS AND RHEUMATISM
- Reply
- (2010) James R. Seibold et al. ARTHRITIS AND RHEUMATISM
- Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model
- (2010) Niloufar Kavian et al. ARTHRITIS AND RHEUMATISM
- A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
- (2010) JS Swaney et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
- (2010) S. G. Adler et al. Clinical Journal of the American Society of Nephrology
- TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
- (2010) Lynne A. Murray et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Epigenetics and autoimmunity
- (2010) Wesley H. Brooks et al. JOURNAL OF AUTOIMMUNITY
- Epithelial Cells Promote Fibroblast Activation via IL-1α in Systemic Sclerosis
- (2010) Nima Aden et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Autoantibodies as predictive tools in systemic sclerosis
- (2010) Svetlana I. Nihtyanova et al. Nature Reviews Rheumatology
- A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts
- (2010) Z. Yin et al. RHEUMATOLOGY
- Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertension
- (2010) C. J. Valerio et al. RHEUMATOLOGY
- Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial
- (2010) A. Kuhn et al. RHEUMATOLOGY
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention
- (2010) M. Konigshoff et al. THORAX
- Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study
- (2010) David Price et al. BMC Pulmonary Medicine
- CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease
- (2009) Bruce L. Riser et al. AMERICAN JOURNAL OF PATHOLOGY
- Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis
- (2009) Jean-François Classen et al. ARTHRITIS AND RHEUMATISM
- Loss of peroxisome proliferator-activated receptor γ in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis
- (2009) Mohit Kapoor et al. ARTHRITIS AND RHEUMATISM
- Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis
- (2009) Hossein Hemmatazad et al. ARTHRITIS AND RHEUMATISM
- Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis
- (2009) Alfiya Akhmetshina et al. ARTHRITIS AND RHEUMATISM
- Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury
- (2009) J Cortijo et al. BRITISH JOURNAL OF PHARMACOLOGY
- A TGFβ-Responsive Gene Signature Is Associated with a Subset of Diffuse Scleroderma with Increased Disease Severity
- (2009) Jennifer L. Sargent et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Association Between a CTGF Gene Polymorphism and Systemic Sclerosis in a French Population
- (2009) B. GRANEL et al. JOURNAL OF RHEUMATOLOGY
- Observational Study of Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
- (2009) A. L. HERRICK et al. JOURNAL OF RHEUMATOLOGY
- Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study
- (2009) S.I. Nihtyanova et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
- (2008) C P Denton et al. ANNALS OF THE RHEUMATIC DISEASES
- Adenosine A2A Receptor Blockade or Deletion Diminishes Fibrocyte Accumulation in the Skin in a Murine Model of Scleroderma, Bleomycin-induced Fibrosis
- (2008) Majid Katebi et al. INFLAMMATION
- Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?
- (2008) Jo N. Fleming et al. PLoS One
- Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis
- (2008) J. H. W. Distler et al. RHEUMATOLOGY
- Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis
- (2007) Khalid Puthawala et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
- (2007) Gerald S. Horan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now